Medication info

K-Bis Tablet

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Kyungbo Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201902400 · Approved 2019.04.18

This product's status changed to Approval withdrawn on 2023.09.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastrointestinal disorders (such as ulcers), treatment of Zollinger-Ellison syndrome, and prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, regardless of meals, take 2 tablets orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by taking 4 tablets twice daily, in the morning and at bedtime. The same dose applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and usually within 8 weeks, although the healing period may occasionally be longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Take 2 tablets 2 hours before induction of anesthesia. It is also preferable to take 2 tablets on the night before surgery.

Ingredients

Manufacturer
Kyungbo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (such as ulcers), treatment of Zollinger-Ellison syndrome, and prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
View approved original text

This medication is used for the treatment of gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective in preventing postoperative ulcers and treating gastric ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Additionally, it is administered prior to anesthesia to prevent Mendelson's syndrome. It helps improve symptoms of various gastric diseases and aids recovery.

How to take

Adult dose

○ Adults Usually, regardless of meals, take 2 tablets orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by taking 4 tablets twice daily, in the morning and at bedtime. The same dose applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and usually within 8 weeks, although the healing period may occasionally be longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Take 2 tablets 2 hours before induction of anesthesia. It is also preferable to take 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients with poor renal function or those undergoing dialysis. Patients with a history of allergy to this medication or its components should avoid administration. Caution should be exercised in patients with a rare disease called acute porphyria, as this medication may exacerbate symptoms. It is also safe to avoid use in patients who have undergone gastric surgery, pregnant women, women who may become pregnant, and premature or newborn infants. Patients on a potassium-restricted diet should avoid taking this medication. Patients with weak liver function or a history of drug allergy should use this medication with caution. Regular monitoring is required for elderly patients, patients with renal function issues, and those taking NSAIDs in combination. This medication may mask symptoms of stomach cancer, hence patients with gastric ulcers or newly developed dyspeptic symptoms over the age of middle age should check for malignancy prior to treatment. Patients with gastric and duodenal ulcers infected with Helicobacter pylori require eradication therapy. Special attention is needed for patients in severe intensive care, those with hypophosphatemia, and patients with swallowing difficulties. During the course of treatment, allergic reactions, skin rashes, blood abnormalities, liver dysfunction, cardiac arrhythmias, gastrointestinal symptoms, and neurological symptoms may occur rarely, and if any abnormal symptoms arise, medical consultation should occur immediately. It is crucial to avoid long-term use, keep close observation of treatment progress, and use the minimum effective dose. Elderly patients or those with chronic illnesses may have an increased risk of pneumonia while taking this medication. If dizziness or drowsiness occurs, driving or operating dangerous machinery should be avoided. This medication may interact with other drugs, so if taking other medications, it is essential to inform the healthcare provider. It is safer for pregnant or breastfeeding women not to use this medication. Safety in children has not been established, so its use is not recommended. In case of overdose, treatments like vomiting or gastric lavage may be necessary, and in some cases, hemodialysis may be required for removal. This medication reduces gastric acid secretion, potentially promoting bacterial proliferation in the stomach, hence ocular examinations may be required for long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 56 more
  • thrombocytopenia
  • elevation of serum creatinine
  • elevation of serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelofibrosis
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundiced hepatitis
  • non-jaundiced hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness of the head
  • sense of illness
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • myotonic contractions
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • joint pain
  • muscle pain
  • rhabdomyolysis
  • alopecia
  • glossitis
  • skin itching
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in an airtight container and kept at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.